My laboratory's research focuses on delineating the key molecular drivers of breast cancer subtype-specific phenotypes with special emphasis on the contributions of the tumorigenic and metastatic tumor microenvironment (TME). In addition, we seek to identify novel therapeutic targets to disrupt critical TME signaling. To achieve these goals, our work combines novel mouse and cell line models of breast development and cancer with patient-derived tissue studies.